Khosla, VCs Plow $100 Million Into Blood Test Startup Using AI (Correct)

Blood-testing company Karius Inc. raised $100 million in a new funding round from investors, and will use the cash to get its technology for detecting hard-to-identify infections into more hospitals.

The funding round was led by existing investor Khosla Ventures alongside 5AM Ventures and Gilde Healthcare. The company declined to give its valuation.

Redwood City, California-based Karius’ blood tests look for pathogens by comparing fragments of microbial DNA with a database of 20,000 genomic references, essentially an atlas of bacteria, parasites and more. The tool can usually hone in on the infection within 26 hours, the company said, considerably shorter than many hospital tests.

To help analyze data quickly, the company ...